Bharat Book

Global Infectious Diseases Partnering

Press Release   •   Feb 04, 2017 14:10 IST

Global Infectious Diseases Partnering 2010-2017: Deal trends, players and financials report provides comprehensive understanding and unprecedented access to the infectives partnering deals and agreements entered into by the worlds leading healthcare companies.

Trends in Infectious Diseases partnering deals

Financial deal terms for headline, upfront and royalty by stage of development

Infectious Diseases partnering agreement structure

Infectious Diseases partnering contract documents

Infectious Diseases deals by value

Most active Infectious Diseases dealmakers

Most of the deals included within the report occur when a licensee obtains a right or an option right to license a licensor’s product or technology. More often these days these deals tend to be multi-component including both a collaborative R&D and a commercialization of outcomes element.

The report takes readers through the comprehensive Infectious Diseases disease deal trends, key players and deal values allowing the understanding of how, why and under what terms companies are currently entering Infectious Diseases deals.

The report presents financial deal terms values for Infectious Diseases deals, where available listing by overall headline values, upfront payments, milestones and royalties enabling readers to analyse and benchmark the value of current deals.

The initial chapters of this report provide an orientation of Infectious Diseases dealmaking trends.

In addition, a comprehensive appendix is provided with each report of all Infectious Diseases partnering deals signed and announced since 2010. The appendices are organized by company A-Z, stage of development at signing, deal type (collaborative R&D, co-promotion, licensing etc) and technology type. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

The report also includes numerous tables and figures that illustrate the trends and activities in Infectious Diseases partnering and dealmaking since 2010.

In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of Infectious Diseases technologies and products.

Report scope

Global Infectious Diseases Partnering 2010 to 2017 is intended to provide the reader with an in-depth understanding and access to Infectious Diseases trends and structure of deals entered into by leading companies worldwide.

Global Infectious Diseases Partnering 2010 to 2017 includes:

Trends in Infectious Diseases dealmaking in the biopharma industry since 2010

Analysis of Infectious Diseases deal structure

Access to headline, upfront, milestone and royalty data

Access to hundreds of Infectious Diseases deal contract documents

Comprehensive access to over 3500 Infectious Diseases deal records

The leading Infectious Diseases deals by value since 2010

Most active Infectious Diseases dealmakers since 2010

In Global Infectious Diseases Partnering 2010 to 2017, available deals and contracts are listed by:

Headline value

Upfront payment value

Royalty rate value

Stage of development at signing

Deal component type

Technology type

Specific therapy indication

Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

The Global Infectious Diseases Partnering 2010-2017 report provides comprehensive access to available deals and contract documents for over 1,500 infectious diseases deals. Analyzing actual contract agreements allows assessment of the following:

What are the precise rights granted or optioned?

What is actually granted by the agreement to the partner company?

What exclusivity is granted?

What is the payment structure for the deal?

How are the sales and payments audited?

What is the deal term?

How are the key terms of the agreement defined?

How are IPRs handled and owned?

Who is responsible for commercialization?

Who is responsible for development, supply, and manufacture?

How is confidentiality and publication managed?

How are disputes to be resolved?

Under what conditions can the deal be terminated?

What happens when there is a change of ownership?

What sublicensing and subcontracting provisions have been agreed?

Which boilerplate clauses does the company insist upon?

Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?

Which jurisdiction does the company insist upon for agreement law?

Global Infectious Diseases Partnering 2010 to 2017 provides the reader with the following key benefits:

In-depth understanding of Infectious Diseases deal trends since 2010

Access Infectious Diseases deal headline, upfront, milestone and royalty data

Research hundreds of actual contracts between Infectious Diseases partner companies

Comprehensive access to over 750 links to actual Infectious Diseases deals entered into by the world’s biopharma companies

Indepth review of Infectious Diseases deals entered into by the top 25 most active dealmakers

Benchmark the key deal terms companies have agreed in previous deals

Identify key terms under which companies partner Infectious Diseases opportunities

Uncover companies actively partnering Infectious Diseases opportunities

Table of Contents
1. Introduction
2. Trends in Infectious Diseases dealmaking
3. Financial deal terms for Infectious Diseases partnering
4. Leading Infectious Diseases deals and dealmakers
5. Infectious Diseases contract document directory
6. Infectious Diseases dealmaking by therapeutic target
7. Appendices

For More Related ReportsHealthcare Market Research Reports & Industry Analysis

Contact us at:
Bharat Book Bureau
Tel: +91 22 27810772 / 27810773
Email: poonam@bharatbook.com
Our Blog:https://www.bharatbook.com/blog/
Follow us on Facebook:https://www.facebook.com/BharatBook3B
Follow us on Twitter:https://twitter.com/researchbook
Follow us on Linked In: http://www.linkedin.com/company/bharat-book-bureau

Bharat Book Bureau, the leading market research information aggregator provides market research reports, company profiles, country reports, newsletters, and online databases for the past twenty four years to corporate, consulting firms, academic institutions, government departments, agencies etc., globally, including India. Our market research reports help global companies to know different market before starting up business / expanding in different countries across the world.